Entera Bio
Funding reported, $275M, last update 3 weeks ago
Pharma biotech · Headquarters Israel
Everything we hold on Entera Bio, newest first. Every line links to the filing or report it came from.
- 2026-07-27Headcount Not Stated Growing and expanding
Entera Bio raises $275m for Phase III osteoporosis drug trial
Entera Bio has $275m of new capital. The report does not disclose hiring plans; watch its careers page for new roles.
- 2026-07-16Headcount Not Stated Leadership moves
Entera Bio Ltd. 8-K filing (Item 5.02): officer or director change
Entera Bio Ltd. has announced a leadership change in Jerusalem, with no immediate impact on headcount disclosed.
- 2025-12-31Pay Change Pay and benefits
ENTERA BIO LTD.: $1,482,000 total compensation for the principal executive officer, fiscal year ended 2025-12-31
Top-of-house pay is the anchor the rest of an employer's pay structure is set against, and it is the one compensation figure every US-listed company must publish on the same basis. Read it as a comparable, not as a salary band: it is a single officer's total, including equity awards valued under SEC rules, and it says nothing directly about what a given role pays.
- 2024-12-31Pay Change Pay and benefits
ENTERA BIO LTD.: $1,149,000 total compensation for the principal executive officer, fiscal year ended 2024-12-31
Top-of-house pay is the anchor the rest of an employer's pay structure is set against, and it is the one compensation figure every US-listed company must publish on the same basis. Read it as a comparable, not as a salary band: it is a single officer's total, including equity awards valued under SEC rules, and it says nothing directly about what a given role pays.
Entera Bio. Talent Intelligence Tracker, AskTheRecruiter.com. Accessed Aug 20, 2026. https://asktherecruiter.com/blog/talent-intelligence-tracker/company/entera-bio/ Licensed CC BY 4.0; every record links to the document behind it.The read-through on each line is our interpretation. The headline and figures come from the linked source. Data licensed CC BY 4.0. Back to the tracker